Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Zhangyanming tablet plus sodium hyaluronate eye drops for dry eye disease
ChiCTR2100045252Phase 4Completed
- Sponsor
- Zhengzhou Second People's Hospital
- Start
- Oct 2020
- Modality
- Small Molecules, Implantable Devices → Device-based Delivery → Drug Delivery Systems, Transdermal Patches → Device-based Delivery → Drug Delivery Systems
- Countries
- 1
01
Overview
Phase 4, randomised trial of zhangyanming in dry eye syndrome (DED) (2 arms), sponsored by Zhengzhou Second People's Hospital. Primary endpoints: Breakup time of tear film (BUT), Tear secretion amount (Schirmer I test, SIT) and 1 more. Started Oct 2020; status: completed.
02
Drugs
zhangyanming
03
Conditions
dry eye syndrome (DED)
Beyond the preview
Go deeper on ChiCTR2100045252.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR2100045252.